Psychiatry & Neurology, Forensic Psychiatry · Los Angeles, CA
NPI
1568488963
Since 2006
Specialty
Psychiatry & Neurology, Forensic Psychiatry
Code 2084F0202X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
12300 Wilshire Blvd Ste 330
Los Angeles, CA, 90025
Phone (310) 829-1924
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$42K
904 prescriptions
Company payments, 2025
$202
From 3 companies
Medicare prescription drug claims, 2024
In 2024, the drug Paul B Bohn prescribed most often to Medicare patients was Alprazolam, with 92 prescriptions and refills. In total Paul B Bohn wrote 904 Medicare prescriptions that cost $42K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-11.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Alprazolam Generic | 92 | 100 | 14 | $504 |
| Clonazepam Generic | 90 | 116 | 11 | $724 |
| Bupropion Xl Bupropion Hcl | 70 | 162 | 15 | $1,442 |
| Trazodone Hcl Generic | 57 | 114 | 13 | $504 |
| Fluoxetine Hcl Generic | 46 | 112 | Under 11 | $386 |
| Escitalopram Oxalate Generic | 45 | 116 | Under 11 | $933 |
| Lorazepam Generic | 33 | 33 | Under 11 | $141 |
| Temazepam Generic | 33 | 33 | Under 11 | $1,044 |
| Aripiprazole Generic | 29 | 51 | Under 11 | $1,501 |
| Zolpidem Tartrate Generic | 28 | 30 | Under 11 | $99.97 |
| Lamotrigine Generic | 28 | 78 | Under 11 | $654 |
| Duloxetine Hcl Generic | 26 | 60 | Under 11 | $646 |
| Mirtazapine Generic | 26 | 42 | Under 11 | $278 |
| Desvenlafaxine Succinate Er Desvenlafaxine Succinate | 24 | 32 | Under 11 | $2,248 |
| Sertraline Hcl Generic | 20 | 54 | Under 11 | $395 |
Brand drugs: 62 claims; generic drugs: 842 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Paul B Bohn $202 ($202 in general payments such as food, travel and fees) from 3 companies. The largest payer was ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) with $86.7.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.